18 December 2000: The Biosafety Advisory Council a.i. issues an advice (positive with conditions) for this trial (the advice is written in French)
EU record number
B/BE/00/V15
Company / Sponsor
Merial
Treated organism
Horses
Indication category
vaccination against equine influenza virus
Genetic modification
haemagglutinin gene from equine influenza virus A2/Kentucky/94 or equine influenza virus A2/Newmarket/2/93
Method of transfer of nucleic acid of interest
Canarypoxvirus (ALVAC clone)
Route of administration
Intramuscular
Locations in Belgium
Gentbrugge and Bornem
Nr of subjects
50
Foreseen duration
12 months
Type of procedure
Deliberate release only